---
input_text: Exploring the Impact of Polysaccharide-Based Nanoemulsions in Drug Delivery.
  Nanoemulsions are tiny mixtures of water and oil stabilized by surfactants, and
  they have become increasingly popular across various industries, including medicine.
  With droplet sizes in the nanometer scale, these mixtures are both compact and effective.
  This discussion explores the potential of polysaccharide-based nanotechnology as
  an innovative approach to drug delivery. Nanoemulsions offer several benefits, such
  as enhanced drug solubility and bioavailability, which are crucial for drugs that
  poorly dissolve in water. The incorporation of natural polysaccharides as emulsifiers
  in these nanoemulsions ensures their biocompatibility and safety within the body.
  Additionally, nanoemulsions can facilitate a sustained release of medications, allowing
  for gradual drug release over an extended period. This controlled release can be
  achieved through the careful selection and formulation of polysaccharides. This
  review addresses the methods for producing polysaccharide-based nanoemulsions and
  examines their physical and chemical properties. It highlights the influence of
  polysaccharide molecular weight and structure on the stability of nanoemulsions
  and the effectiveness of drug encapsulation. By understanding these factors, researchers
  can develop more efficient and safe drug delivery systems utilizing nanoemulsions.
  Additionally, the present article provides explicit and thorough information about
  the use of NPLS-based nano-carriers encapsulating a number of drugs designed to
  treat a variety of conditions, such as diabetes, cancer, HIV, malaria, cardiovascular
  and respiratory diseases, and skin diseases. For this reason, it is very important
  to review the most recent developments in polysaccharide-based nano-biocarriers
  in drug delivery and their application in the treatment of diseases. In this work,
  we concentrated on the preparation of polysaccharide-based nano-biocarriers, commonly
  used polysaccharides for the preparation of nano-biocarriers, and drugs loaded on
  polysaccharide-based nano-biocarriers to treat diseases. In the near future, polysaccharide-based
  nano-biocarriers will be used more and more frequently in drug delivery and disease
  treatment.
raw_completion_output: |-
  primary_disease: <Drug delivery inefficiencies>
  medical_actions: <Using polysaccharide-based nanoemulsions for drug delivery; Encapsulating drugs in NPLS-based nano-carriers; Preparing polysaccharide-based nano-biocarriers>
  symptoms: <Not applicable (The text does not directly mention symptoms)>
  chemicals: <Polysaccharides; NPLS-based nano-carriers>
  action_annotation_relationships: <Using polysaccharide-based nanoemulsions for drug delivery PREVENTS Drug delivery inefficiencies; Encapsulating drugs in NPLS-based nano-carriers PREVENTS Drug delivery inefficiencies; Preparing polysaccharide-based nano-biocarriers PREVENTS Drug delivery inefficiencies>
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Preparing polysaccharide-based nano-biocarriers PREVENTS Drug delivery inefficiencies>

  ===

extracted_object:
  primary_disease: <Drug delivery inefficiencies>
  medical_actions:
    - <Using polysaccharide-based nanoemulsions for drug delivery
    - Encapsulating drugs in NPLS-based nano-carriers
    - Preparing polysaccharide-based nano-biocarriers>
  symptoms:
    - <Not applicable (The text does not directly mention symptoms)>
  chemicals:
    - <Polysaccharides
    - NPLS-based nano-carriers>
  action_annotation_relationships:
    - subject: <drug delivery>
      predicate: <PREVENTS>
      object: <Drug delivery inefficiencies>
      subject_extension: <polysaccharide-based nanoemulsions>
    - subject: Encapsulating drugs
      predicate: PREVENTS
      object: Drug delivery inefficiencies
      subject_extension: NPLS-based nano-carriers
    - subject: Preparing polysaccharide-based nano-biocarriers
      predicate: PREVENTS
      object: Drug delivery inefficiencies
      subject_extension: polysaccharide-based nano-biocarriers
named_entities:
  - id: MONDO:0005136
    label: Malaria
  - id: MONDO:0017014
    label: children
